相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Genetic Basis and Expanding Role of Molecular Analysis in the Diagnosis, Prognosis, and Therapeutic Design for Myelodysplastic Syndromes
Grant E. Nybakken et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2014)
Circulating microRNAs in hematological diseases: principles, challenges, and perspectives
Sarah Grasedieck et al.
BLOOD (2013)
MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth
Bisheng Zhou et al.
CANCER LETTERS (2013)
Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes
Diamantina Vasilatou et al.
LEUKEMIA RESEARCH (2013)
Leukemia cell to endothelial cell communication via exosomal miRNAs
T. Umezu et al.
ONCOGENE (2013)
Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection
Enders K. O. Ng et al.
PLOS ONE (2013)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
MiR-96 Downregulates REV1 and RAD51 to Promote Cellular Sensitivity to Cisplatin and PARP Inhibition
Yemin Wang et al.
CANCER RESEARCH (2012)
miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver
Koji Okamoto et al.
EMBO JOURNAL (2012)
MicroRNAs miR-96, miR-124, and miR-199a regulate gene expression in human bone marrow-derived mesenchymal stem cells
Salla K. Laine et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge
Julie Schanz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Tumor Suppressor MicroRNA-493 Decreases Cell Motility and Migration Ability in Human Bladder Cancer Cells by Downregulating RhoC and FZD4
Koji Ueno et al.
MOLECULAR CANCER THERAPEUTICS (2012)
MiR-25 Regulates Wwp2 and Fbxw7 and Promotes Reprogramming of Mouse Fibroblast Cells to iPSCs
Dong Lu et al.
PLOS ONE (2012)
MicroRNA Expression Profiles of Whole Blood in Lung Adenocarcinoma
Santosh K. Patnaik et al.
PLOS ONE (2012)
MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme
Sung-Suk Suh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
FLT3 and NPM1 Mutations in Myelodysplastic Syndromes Frequency and Potential Value for Predicting Progression to Acute Myeloid Leukemia
Ashish Bains et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome
Zhuang Zuo et al.
BLOOD (2011)
Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: A case control study
Wangyu Zhu et al.
BMC CANCER (2011)
Association of Comorbidities With Overall Survival in Myelodysplastic Syndrome: Development of a Prognostic Model
Kiran Naqvi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL
Xiaoyu Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
MicroRNAs in body fluids-the mix of hormones and biomarkers
Maria Angelica Cortez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Negative regulation of the tumor suppressor p53 gene by microRNAs
M. Kumar et al.
ONCOGENE (2011)
FLT3 internal tandem duplication associates with adverse outcome and gene-and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
Susan P. Whitman et al.
BLOOD (2010)
miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death
Lorenzo Galluzzi et al.
CANCER RESEARCH (2010)
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
Nobuyoshi Kosaka et al.
CANCER SCIENCE (2010)
The miR-144/451 locus is required for erythroid homeostasis
Kasper D. Rasmussen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells
A. Pellagatti et al.
LEUKEMIA (2010)
Exosomes from human saliva as a source of microRNA biomarkers
A. Michael et al.
ORAL DISEASES (2010)
Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells
Lucy Pigati et al.
PLOS ONE (2010)
Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer Detection
Noh Jin Park et al.
CLINICAL CANCER RESEARCH (2009)
Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
NATURE REVIEWS GENETICS (2009)
Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients
Masami Tanaka et al.
PLOS ONE (2009)
Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs
Dana E. Rollison et al.
BLOOD (2008)
Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
Hagop Kantarjian et al.
CANCER (2008)
Direct multiplexed measurement of gene expression with color-coded probe pairs
Gary K. Geiss et al.
NATURE BIOTECHNOLOGY (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A prognostic score for patients with lower risk myelodysplastic syndrome
G. Garcia-Manero et al.
LEUKEMIA (2008)
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes
Luca Malcovati et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Adjusting batch effects in microarray expression data using empirical Bayes methods
W. Evan Johnson et al.
BIOSTATISTICS (2007)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
分享论文
